Formycon AG (LON:0W4N)
London · Delayed Price · Currency is GBP · Price in EUR 19.82
-1.13 (-5.39%)
At close: Nov 5, 2025
Formycon AG Employees
Formycon AG had 250 employees as of December 31, 2024. The number of employees increased by 12 or 5.04% compared to the previous year.
Employees
250
Change (1Y)
12
Growth (1Y)
5.04%
Revenue / Employee
181.16K GBP
Profits / Employee
-593.98K GBP
Market Cap
310.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 250 | 12 | 5.04% |
| Dec 31, 2023 | 238 | 33 | 16.10% |
| Dec 31, 2022 | 205 | 34 | 19.88% |
| Dec 31, 2021 | 171 | 40 | 30.53% |
| Dec 31, 2020 | 131 | 18 | 15.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Formycon AG News
- 16 days ago - Formycon, Teva Pharma Launch FYB201/Ranivisio Biosimilar In Pre-filled Syringe In Europe - Nasdaq
- 5 weeks ago - Formycon Reaches Settlement With Regeneron Over U.S. Eylea Biosimilar Patent Disputes - Nasdaq
- 7 weeks ago - Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy • news - Onvista